These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
340 related items for PubMed ID: 12649366
1. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys. Ko MC, Lee H, Song MS, Sobczyk-Kojiro K, Mosberg HI, Kishioka S, Woods JH, Naughton NN. J Pharmacol Exp Ther; 2003 Apr; 305(1):173-9. PubMed ID: 12649366 [Abstract] [Full Text] [Related]
2. The role of central mu opioid receptors in opioid-induced itch in primates. Ko MC, Song MS, Edwards T, Lee H, Naughton NN. J Pharmacol Exp Ther; 2004 Jul; 310(1):169-76. PubMed ID: 15044556 [Abstract] [Full Text] [Related]
4. An experimental itch model in monkeys: characterization of intrathecal morphine-induced scratching and antinociception. Ko MC, Naughton NN. Anesthesiology; 2000 Mar; 92(3):795-805. PubMed ID: 10719958 [Abstract] [Full Text] [Related]
5. Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys. Ko MC, Willmont KJ, Lee H, Flory GS, Woods JH. Brain Res; 2003 Aug 22; 982(1):38-44. PubMed ID: 12915238 [Abstract] [Full Text] [Related]
9. Kappa opioid antagonist effects of the novel kappa antagonist 5'-guanidinonaltrindole (GNTI) in an assay of schedule-controlled behavior in rhesus monkeys. Negus SS, Mello NK, Linsenmayer DC, Jones RM, Portoghese PS. Psychopharmacology (Berl); 2002 Oct 22; 163(3-4):412-9. PubMed ID: 12373442 [Abstract] [Full Text] [Related]
13. Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay. Wettstein JG, Grouhel A. Pharmacol Biochem Behav; 1996 Feb 22; 53(2):411-6. PubMed ID: 8808151 [Abstract] [Full Text] [Related]
14. Effects of Intrathecal κ-Opioid Receptor Agonist on Morphine-Induced Itch and Antinociception in Mice. Sakakihara M, Imamachi N, Saito Y. Reg Anesth Pain Med; 2016 Feb 22; 41(1):69-74. PubMed ID: 26587674 [Abstract] [Full Text] [Related]
15. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse. Mizoguchi H, Spaulding A, Leitermann R, Wu HE, Nagase H, Tseng LF. J Pharmacol Exp Ther; 2003 Jul 22; 306(1):394-400. PubMed ID: 12721333 [Abstract] [Full Text] [Related]
16. Thienorphine: receptor binding and behavioral effects in rhesus monkeys. Li JX, Becker GL, Traynor JR, Gong ZH, France CP. J Pharmacol Exp Ther; 2007 Apr 22; 321(1):227-36. PubMed ID: 17220427 [Abstract] [Full Text] [Related]
17. Spinal kappa-opioid system plays an important role in suppressing morphine withdrawal syndrome in the rat. Cui CL, Wu LZ, Han JS. Neurosci Lett; 2000 Dec 01; 295(1-2):45-8. PubMed ID: 11078933 [Abstract] [Full Text] [Related]
18. Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice. Narita M, Takahashi Y, Takamori K, Funada M, Suzuki T, Misawa M, Nagase H. Jpn J Pharmacol; 1993 May 01; 62(1):15-24. PubMed ID: 8393497 [Abstract] [Full Text] [Related]
19. Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys. Ko MC, Butelman ER, Woods JH. J Pharmacol Exp Ther; 1999 Apr 01; 289(1):378-85. PubMed ID: 10087027 [Abstract] [Full Text] [Related]
20. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus. Morgenweck J, Frankowski KJ, Prisinzano TE, Aubé J, Bohn LM. Neuropharmacology; 2015 Dec 01; 99():600-9. PubMed ID: 26318102 [Abstract] [Full Text] [Related] Page: [Next] [New Search]